Manufacturer/Distributor: Square Pharmaceuticals Ltd.
Side effects: See under ‘salbutamol’ & ‘ipratropium bromide’ separately.
Precautions and warnings: See under ‘salbutamol’ & ‘ipratropium bromide’ separately.
Pregnancy category:There are no adequate and well-controlled studies of salbutamol & ipratropium bromide combination inhalation aerosol in pregnant women. So, the use of this combination aerosol product for the treatmnt of COPO during pregnancy and labor should be restricte
Child: Children (below 12 years): Not recommended .
Therapeutic class: Salbutamol + Ipratropium
Dosage and administrations: Adults (including the elderly and adolescents over 12 years of age): The dose of this combined inhalation aerosol is 2 puffs 4 times a day. Patients may take additional inhalations as required; however, the total number of inhalations should not exceed 12
Indication: This combined inhalation aerosol is indicated for use in patients with chronic obstructive pulmonary disease (COPD) on a regular aerosol bronchodilator who continue to have evidence of bronchospasm and who require a second bronchodilator.
Composition action: See under ‘salbutamol’ & ‘ipratropium bromide’ separately.